Our Comment:
The most important thing seems to be to keep the estrogen dose low: as a rule 30 µg ethinylestradiol are enough. The newer progestogens (desogestrel, gestodene, norgestimate) do not influence the lipids as much as the ones that have been known for a longer time. Whether they really involve fewer complications than e.g. levonorgestrel still has to be safely established in longer studies. The massive price increase in the last few years is striking.